In my father’s printing shop in Bologna, we understood that a page is only as reliable as the press that produces it. If the machine is misaligned, the truth becomes a smudge.
For millions of families navigating the slow, terrifying decline that accompanies Alzheimer’s disease, the greatest struggle has always been uncertainty.
When you read about a massive food recall, involving jalapeños that traveled from Sinaloa, Mexico, to shelves at Walmart, Target, Trader Joe’s, and Whole Foods, it sounds like bad luck.
The details are always the same when Washington decides to play God with basic medicine. First, there’s the technological breakthrough—in this case, Moderna's mFlusiva, an mRNA-based flu vaccine.
The current flurry of headlines about Cyclospora cayetanensis is a textbook example of how quickly localized biological threats can balloon into national crises through sheer information density.